Association of Eif3 P170 Expression with Chemotherapy Response of Lung Cancer and Its Effects on Cisplatin Sensitivity in Lung Carcinoma Cells
Jie Shen,Hai Tang Xie,Ji Ye Yin,Hong Hao Zhou,Jing Ting Zhang,Zhao Qian Liu
DOI: https://doi.org/10.1016/j.cellbi.2008.01.141
IF: 4.473
2008-01-01
Cell Biology International
Abstract:Cell Biology InternationalVolume 32, Issue 3 p. S32-S32 Association of eIF3 p170 expression with chemotherapy response of lung cancer and its effects on cisplatin sensitivity in lung carcinoma cells Jie Shen, Jie Shen Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University Xiang-Ya School of Medicine, Changsha, Hunan 410078, ChinaSearch for more papers by this authorHai Tang Xie, Hai Tang Xie Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University Xiang-Ya School of Medicine, Changsha, Hunan 410078, ChinaSearch for more papers by this authorJi Ye Yin, Ji Ye Yin Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University Xiang-Ya School of Medicine, Changsha, Hunan 410078, ChinaSearch for more papers by this authorHong Hao Zhou, Hong Hao Zhou Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University Xiang-Ya School of Medicine, Changsha, Hunan 410078, ChinaSearch for more papers by this authorJing Ting Zhang, Jing Ting Zhang Department of Pharmacology & Toxicology, I.U. Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USASearch for more papers by this authorZhao Qian Liu, Zhao Qian Liu Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University Xiang-Ya School of Medicine, Changsha, Hunan 410078, ChinaSearch for more papers by this author Jie Shen, Jie Shen Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University Xiang-Ya School of Medicine, Changsha, Hunan 410078, ChinaSearch for more papers by this authorHai Tang Xie, Hai Tang Xie Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University Xiang-Ya School of Medicine, Changsha, Hunan 410078, ChinaSearch for more papers by this authorJi Ye Yin, Ji Ye Yin Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University Xiang-Ya School of Medicine, Changsha, Hunan 410078, ChinaSearch for more papers by this authorHong Hao Zhou, Hong Hao Zhou Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University Xiang-Ya School of Medicine, Changsha, Hunan 410078, ChinaSearch for more papers by this authorJing Ting Zhang, Jing Ting Zhang Department of Pharmacology & Toxicology, I.U. Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USASearch for more papers by this authorZhao Qian Liu, Zhao Qian Liu Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Central South University Xiang-Ya School of Medicine, Changsha, Hunan 410078, ChinaSearch for more papers by this author First published: 02 January 2013 https://doi.org/10.1016/j.cellbi.2008.01.141AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume32, Issue3March 2008Pages S32-S32 RelatedInformation